A paired comparison of dental care in Canadians with Down syndrome and their siblings without Down syndrome.

There has been increasing public concern about the risks of high dose antipsychotic treatment which has partly been due to the association of high dose treatment and death in a small number of patients, although this has as yet been unproven. (Hirsch and Barnes,1994; Brown and Kocsis,1984; Simpson,...

Descripción completa

Detalles Bibliográficos
Publicado en:Community Dentistry & Oral Epidemiology Vol. 32; no. 2; pp. 99 - 107
Autores principales: Allison PJ, Lawrence HP
Formato: research tables/charts Journal Article
Publicado: Wiley-Blackwell Apr2004
Acceso en línea:Ver este registro en EBSCOhost
fields @attributes:
  recordID: 1
pdfLink:
plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=106561799&site=ehost-live
header:
  @attributes:
    shortDbName: ccm
    uiTerm: 106561799
    longDbName: CINAHL Complete
    uiTag: AN
  controlInfo:
    bkinfo:
    dissinfo:
    jinfo:
      jid:
        03015661
        HXZ
      jtl: Community Dentistry & Oral Epidemiology
      issn: 03015661
      maglogo: Y
    pubinfo:
      dt: Apr2004
      vid: 32
      iid: 2
      pid: 480
      pub: Wiley-Blackwell
      place: Malden, Massachusetts
    artinfo:
      ui:
        106561799
        106561799
        2005017069
        10.1111/j.0301-5661.2004.00130.x
        NLM15061858
        106561799
      ppf: 99
      ppct: 8
      formats:
      tig:
        atl: A paired comparison of dental care in Canadians with Down syndrome and their siblings without Down syndrome.
      aug:
        au:
          Allison PJ
          Lawrence HP
        affil: Faculty of Dentistry, McGill University, 3640, University St, Montreal, Quebec, Canada H3A 2B2; paul.allison@mcgill.ca
      sug:
        subj:
          Dental Care Canada
          Down Syndrome
          Adolescence
          Adult
          Canada
          Child
          Child, Preschool
          Comparative Studies
          Cross Sectional Studies
          Descriptive Statistics
          Hypothesis
          Mail
          McNemar's Test
          Questionnaires
          Siblings
          Survey Research
          Funding Source
          Human
          Adolescent: 13-18 years
          Adult: 19-44 years
          Child: 6-12 years
          Child, Preschool: 2-5 years
      ab: There has been increasing public concern about the risks of high dose antipsychotic treatment which has partly been due to the association of high dose treatment and death in a small number of patients, although this has as yet been unproven. (Hirsch and Barnes,1994; Brown and Kocsis,1984; Simpson, et al., 1987). In patients with learning disabilities, antipsychotic medication is used not only for defined psychiatric illness but also for the control of aggressive and disturbed behaviour, hyperactivity and stereotypical behaviour in the absence ofmental illness for which there is no consensus among psychiatrists (Santosh and Baird,1999; Fernando, et.al., 1997). Learning disabled patients pose further problems in that they may lack capacity and hence be unable to give informed consent for the use of high dose antipsychotic medication and the treatment response may be difficult to evaluate.Diagnosis of psychosis becomes a specialist task as there are special difficulties of communication. In addition, these patients may be particularly sensitive to side effects as a result of previous cerebral dysfunction or damage and hence the thresh-old for 'high doses' is lower. It may be difficult to recognise these side effects and the presence of cardiac and renal problems may be missed as a complete medical history may not be available. Antipsychotic medication reduces the seizure threshold and this may result in worsening of seizures or an increase in the required dose of the antiepileptic, as a high proportion of learning disabled patients suffer from epilepsy.In view of all these problems, particularly in patients with learning disability, it is important that when prescribing high dose antipsychotics, the guidelines de-scribed in this audit should be adhered to. This audit highlights those standards which were poorly complied with and suggests that the use of a checklist would greatly improve current practice. It is planned to repeat the audit in 6 months time to elicit if the authors' recommendations have improved clinical practice.
      pubtype: Academic Journal
      doctype:
        research
        tables/charts
        Journal Article
      ougenre: Article
    language: English
    refInfo:
    holdings:
      @attributes:
        islocal: N